|
|
|
|
| LEADER |
01683nam a2200265 u 4500 |
| 001 |
EB001839966 |
| 003 |
EBX01000000000000001003955 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Neurotrophic stimulation therapy for the management of generalized anxiety disorder and depression
|h Elektronische Ressource
|b a review of the clinical effectiveness
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 20 August 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (29 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Electric Stimulation Therapy
|
| 653 |
|
|
|a Anxiety Disorders / therapy
|
| 653 |
|
|
|a Depressive Disorder / therapy
|
| 653 |
|
|
|a Acupuncture Therapy
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report : summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK349942
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Centers offering neurotrophic stimulation as an approach to managing mental health disorders are available in Canada. The objective of this report is to review the literature for evidence of clinical effectiveness for the use of any component of neurotrophic stimulation alone or in combination with another component in patients with depression or generalized anxiety disorder (GAD). A previous report addressed the clinical effectiveness of neurotrophic stimulation in post-traumatic stress disorder (PTSD) and substance abuse disorders
|